Faculty profile

Thierry Muanza

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

Thierry Muanza

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

420

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Breast Conserving Surgery De-Escalation Neoadjuvant Chemotherapy Pathologic Complete Response Radiation Oncology

Latest papers

Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.
Neuro-oncology practice · 2026
Uterine Transposition Prior to Pelvic Radiation: First Canadian Center.
International journal of radiation oncology, biology, physics · 2026
Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study.
International journal of radiation oncology, biology, physics · 2026

All 29 publications

Latest funding

Engineering metabolically stable molecules toward tandem targeting of EGFR, its variant EGFRvIII and DNA for killing stem cells and preventing recurrence in the treatment of glioblastom multiforme (GBM)
CIHR · 2024 · Co-investigator
$956,250
A prospective trial of radiation omission in patients with clinically node negative breast cancer and pathologic complete response after neoadjuvant chemotherapy.
CIHR · 2021 · Nominated PI
$1,514,700

All 2 grants and awards

29 publications.

Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.

Zerd F, Odukoya LA, Cheserem B, Darko K, Ghomsi NC, Kabare GS, Kamson DO, Eckel-Passow JE, Jenkins RB, Decker P, Llewellyn H, Kitange GJ, Akinjo AO, Badmos KB, Yevudza WE, Bankole O, Idowu OE, Ayanlaja AA, Karekezi C, Edrick E, Ekhator C, Katasi VM, Lachance DH, Huse J, Magambo M, Banti E, Magoha M, Ngaiza A, Nyalundja AD, Higgins D, Okemwa M, Osei-Tutu L, Petershie B, Minja FJ, Anunobi CC, Etame AB, Tiamiyu L, Gankpe GF, Kwikima UM, Heronima K, Schroeder K, Muanza T, Brown DA, Davidson A, Fonkem E, Totimeh T, Balogun J

Neuro-oncology practice2026

DOI: 10.1093/nop/npaf107 PMID: 42131754

Uterine Transposition Prior to Pelvic Radiation: First Canadian Center.

Ribeiro R, Levin G, Muanza T, Gilbert L

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2025.11.040 PMID: 41569225

Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study.

Mehta MP, Gondi V, Ahluwalia MS, Roberge D, Sio TTW, Trifiletti DM, Muanza T, Krpan AM, Zhu Z, Ramakrishna NR, Fiveash JB, Metellus P, Yu J, Wang CJ, Jacob J, Freyschlag CF, Csőszi T, Salmaggi A, Taliansky A, Lucas A, Debus J, Brown PD, Harat M

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2025.08.066 PMID: 41033612

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.

Tonneau M, Phan K, Manem VSK, Low-Kam C, Dutil F, Kazandjian S, Vanderweyen D, Panasci J, Malo J, Coulombe F, Gagné A, Elkrief A, Belkaïd W, Di Jorio L, Orain M, Bouchard N, Muanza T, Rybicki FJ, Kafi K, Huntsman D, Joubert P, Chandelier F, Routy B

Frontiers in oncology2023

DOI: 10.3389/fonc.2023.1196414 PMID: 37546399

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Auclin E, Benitez-Montanez J, Tagliamento M, Parisi F, Gorria T, Garcia-Campelo R, Dempsey N, Pinato DJ, Reyes R, Albarrán-Artahona V, Dall'Olio F, Soldato D, Hendriks L, Nana FA, Tonneau M, Lopez-Castro R, Nadal E, Kazandjian S, Muanza T, Blanc-Durand F, Fabre E, Castro N, Arasanz H, Rochand A, Besse B, Routy B, Mezquita L

Lung cancer (Amsterdam, Netherlands)2023

DOI: 10.1016/j.lungcan.2023.02.002 PMID: 36812760

Neuronal GPR81 regulates developmental brain angiogenesis and promotes brain recovery after a hypoxic ischemic insult.

Chaudhari P, Madaan A, Rivera JC, Charfi I, Habelrih T, Hou X, Nezhady M, Lodygensky G, Pineyro G, Muanza T, Chemtob S

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

DOI: 10.1177/0271678x221077499 PMID: 35107038

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.

Owen S, Alken S, Alshami J, Guiot MC, Kavan P, Reardon DA, Muanza T, Gibson N, Pemberton K, Solca F, Cseh A, Saran F

OncoTargets and therapy2022

DOI: 10.2147/ott.s346725 PMID: 35422631

Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer.

Tejera D, Rana M, Basik M, Boileau JF, Margolese R, Prakash I, Meguerditchian AN, Muanza T, Monette J, Wong SM

Breast cancer research and treatment2021

DOI: 10.1007/s10549-021-06393-3 PMID: 34542772

Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer.

Wong SM, Basik M, Florianova L, Margolese R, Dumitra S, Muanza T, Carbonneau A, Ferrario C, Boileau JF

Annals of surgical oncology2021

DOI: 10.1245/s10434-020-09211-0 PMID: 33095362

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Whelan TJ, Julian JA, Berrang TS, Kim D-H, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A

The Lancet2019420 citations

DOI: 10.1016/s0140-6736(19)32515-2

Something wrong or missing on this profile? Suggest a correction

Thierry Muanza

Research

Latest papers

Latest funding

Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based survey.

Uterine Transposition Prior to Pelvic Radiation: First Canadian Center.

Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study.

Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Neuronal GPR81 regulates developmental brain angiogenesis and promotes brain recovery after a hypoxic ischemic insult.

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.

Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer.

Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Engineering metabolically stable molecules toward tandem targeting of EGFR, its variant EGFRvIII and DNA for killing stem cells and preventing recurrence in the treatment of glioblastom multiforme (GBM)

A prospective trial of radiation omission in patients with clinically node negative breast cancer and pathologic complete response after neoadjuvant chemotherapy.

Frequent collaborators

David Roberge

Danuta Radzioch

Mark Basik

Bertrand Routy

Ipshita Prakash

Philippe Joubert

Arielle Elkrief

Som Mukherjee

Ian Stuart Dayes

Do-Hoon Kim

Mark Norman Levine

Jonathan Sussman

Nada Jabado

Catalin Mihalcioiu

Mark Trifiro

Miltiadis Paliouras

Lucy Gilbert

Harold Reiter

Timothy Whelan